Connect
MJA
MJA

In Other Journals

Sophie McNamara
Med J Aust 2011; 194 (12): . || doi: 10.5694/j.1326-5377.2011.tb03159.x
Published online: 20 June 2011

A comment piece in The Lancet condemns Oxford University’s investment in the arms industry. The article comes three years after Reed Elsevier, publisher of the The Lancet, announced the sale of its arms exhibitions business in response to concerns from readers and authors. The Lancet comment piece, written by a student activist group called Oxford Anti-War Action, argues that Oxford can “no longer ignore the ethical implications of their investment”. Using a freedom of information request, the authors found that Oxford had invested £4.5 million through third-party funds in UK and US arms manufacturers such as Lockheed Martin and BAE Systems, between 2008 and 2010. The authors report that in June 2010, the university’s governing council decided against screening out arms companies from their investment portfolio.




Correspondence: 

Author

remove_circle_outline Delete Author
add_circle_outline Add Author

Comment
Do you have any competing interests to declare? *

I/we agree to assign copyright to the Medical Journal of Australia and agree to the Conditions of publication *
I/we agree to the Terms of use of the Medical Journal of Australia *
Email me when people comment on this article

Online responses are no longer available. Please refer to our instructions for authors page for more information.